| Financial Year |
March 31 2023 |
| Monetary Funds |
688,365,166.10 |
| Held-for-trading Financial Assets |
98,243,167.65 |
| Notes Receivable |
7,550,000.00 |
| Accounts Receivable |
580,333,867.71 |
| Advances to Suppliers |
4,716,476.76 |
| Other Receivables |
30,698,574.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,504,858.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
64,960,663.04 |
| Other Current Assets |
169,277,142.35 |
| Total Current Assets |
1,903,521,345.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,785,674,485.85 |
| Long-term Equity Investment |
27,004,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
119,055,690.60 |
| Under-construction Projects |
1,425,925.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,753,113,677.31 |
| R&D expenses |
-- |
| Goodwill |
32,753,627.50 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
16,399,162.83 |
| Other Non-Current Assets |
90,935,850.20 |
| Sub-Total of Non-Current Assets |
4,847,717,446.67 |
| Total Assets |
6,751,238,791.99 |
| Short-Term Loans |
374,835,753.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,962,964.62 |
| Accounts Payable |
569,782,767.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,373,504.68 |
| Taxes Payable |
17,469,546.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,192,562.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
179,730,426.30 |
| Other Current Liabilities |
32,598,111.12 |
| Sub-Total of Current Liabilities |
1,343,442,726.33 |
| Long-term Loans |
1,465,599,228.52 |
| Bonds Payable |
762,214,973.42 |
| Long-Term Accounts Payable |
381,589,776.49 |
| Special Payable |
-- |
| Estimatied Liabilities |
116,348,113.48 |
| Deferred Income Tax Liabilities |
98,441,516.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,898,394,989.30 |
| Total Liabilities |
4,241,837,715.63 |
| Paid-In Capital(Or Share Stock) |
423,752,983.00 |
| Capital Surplus |
972,482,577.13 |
| Surplus Reserve |
39,581,597.32 |
| LESS:Treasury Stock |
44,189,224.50 |
| Undistributed Profits |
834,254,595.30 |
| Minority Stockholder's Interest |
158,521,857.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,350,879,218.89 |
| Owner's Equity（Stockholder's Equity） |
2,509,401,076.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,751,238,791.99 |
